11/16/2021NMPA Withdraws Approvals of Eight Domestic Drugs

11/16/2021EdiGene Partners with the UWM on in Vivo RNA Editing Therapies

11/16/2021I-Mab and Jumpcan Announce Strategic Commercial Partnership on Eftanso...

11/16/2021Amgen Enters into Strategic Collaboration with Profex to Co-promote Pr...

11/16/2021Innovent's 5th NDA for PD-1 Drug Tyvyt Turned Down by the NMPA 

11/16/2021Janssen Secures Third Chinese Approval for Darzalex to Treat Newly Dia...

11/16/2021BeiGene Cleared for IPO on the Shanghai STAR Market

11/16/2021PharmaDJ's China Biotech Fundraising Tracker: October 2021

11/16/2021PharmaDJ: Chinese American Physicians and Scientists Foster Exchanges ...

11/15/2021China In The Global Pharmaceutical Innovation Race

11/15/2021Luye Pharma Grants Zambon Swiss Rights of Its Alzheimer's Drug Rivas...

11/15/2021CDE Solicits Comments for the Proposed Technical Guidelines for Clinic...

11/15/2021Milestone's Chinese Partner Files Chinese IND for Etripamil

11/15/2021NMPA Issues the List of Reference Formulations for GQCE Studies (48th ...

11/15/2021China to Release the Updated NRDL Soon

11/15/2021NHC Solicits Comments on Draft Revision of the Provisions for National...

11/15/2021Chinese Court Rules against Kangmei Pharma in 'Milestone' Case

11/15/2021FDA Closes Warning Letter to Huahai over Valsartan, Opening Door for t...

11/15/2021HebaBiz Biotech's P3 Trial in China for HBV Drug Clevudine (L-FMAU) ...

11/15/2021SCMP: China May Approve First Covid-19 Drug Within Weeks

11/12/2021CDE Issues the Technical Guidelines for Minimal Residual Disease Detec...

11/12/2021NMPA Solicits Comments on the Draft Provisions for Quality Control of ...

11/12/2021AZ Reports Mixed Q3/2021 Results, As It Begins to Manage Future Expect...

11/11/2021NMPA Hosts Meeting on Drug, Medical Device, Cosmetic Regulation in Chi...

11/11/2021Everest Med and Gilead Announce P2b Study of Sacituzumab Govitecan in ...

11/11/2021Organon Reports Q3/2021 Earnings, Highlighting China Performance

11/11/2021Blueprint Medicines and Zai Lab Announce License Deal for BLU-945 and ...

11/11/2021Karuna Therapeutics and Zai Lab Announce Strategic Partnership for Ka...

11/11/2021Beijing Intellectual Property Court Accepts China's First Drug Patent ...

11/11/2021China Clears Trials on Using mRNA Vaccine as Booster Shot

Page:161/774 Total number of articles:23207: [First][<<] [159] [160] [161] [162] [163] [>>] [End]